Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Erythroderma, Sezary

etoposide has been researched along with Erythroderma, Sezary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agostinelli, C; Grandi, V; Patrizi, A; Pellegrini, C; Pileri, A; Pimpinelli, N; Zinzani, PL1
Arimoto, T; Hara, H; Iwasaki, Y; Kubota, Y; Nakanishi, M; Ueda, M1
Miyoshi, N; Noda, M1
Bernengo, MG; Doveil, GC; Fierro, MT; Quaglino, P; Savoia, P; Verrone, A1
Akpek, G; Bogen, S; Foss, FM; Koh, HK; O'Hara, C1
Hirayama, Y; Koyama, R; Matsunaga, T; Nagai, T; Niitsu, Y; Ohta, H; Sakamaki, S1

Trials

1 trial(s) available for etoposide and Erythroderma, Sezary

ArticleYear
Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Cancer, 1999, Oct-01, Volume: 86, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Prednisone; Remission Induction; Sezary Syndrome; Vincristine

1999

Other Studies

5 other study(ies) available for etoposide and Erythroderma, Sezary

ArticleYear
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome?
    European journal of dermatology : EJD, 2017, Feb-01, Volume: 27, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Dermatitis, Exfoliative; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphadenopathy; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Organoplatinum Compounds; Prednisolone; Prednisone; Sezary Syndrome; Vincristine

2017
[Small cell lung cancer with Sézary syndrome].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:12

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Sezary Syndrome; Small Cell Lung Carcinoma

2009
[Complication of topoisomerase II inhibitor-related acute promyelocytic leukemia with t(1;10) (q21;q26) in a patient with Sézary syndrome].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:5

    Topics: Aged; Antineoplastic Agents, Phytogenic; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Nucleic Acid Synthesis Inhibitors; Sezary Syndrome; Skin Neoplasms

2006
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:3

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Prednisone; Remission Induction; Sezary Syndrome; Skin Neoplasms; Vincristine

1997
[Sézary syndrome showing a stable clinical course for more than four years after oral administration of etoposide and methotrexate].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:9

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Methotrexate; Middle Aged; Sezary Syndrome; Skin Neoplasms; Time Factors

2000